Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Isofol in connection with its listing on Nasdaq Stockholm
Mandate

Vinge advises Isofol in connection with its listing on Nasdaq Stockholm

October 21, 2021 Intellectual Property Capital Markets and Public M&A Commercial Agreements Employment and Benefits Corporate Tax

Vinge has advised Isofol Medical AB in connection with its listing on Nasdaq Stockholm, with the first day of trading on 21 October 2021. The prospectus was approved by the Swedish Financial Supervisory Authority on 18 October 2021. Isofol has a market value corresponding to approximately SEK 1.5 billion.

Isofol is a biotech company in late clinical phase which develops arfolitixorin in order to improve standard treatment of 5-FE based chemotherapy, primarily for advanced colorectal cancer, by increasing tumour response and progression free survival.

Vinge’s team primarily consisted of Anders Strid, Jenny Sandlund and Edin Agic (Capital Markets), Victor Ericsson and Emelie Svanberg (Tax), Anna Ståhlklo (Commercial Agreements), Alexander Lindeberg (IP) and Rebecka Hansson (Employment Law).

Related

Vinge advises Ambea on the acquisition of Validia

 Vinge has acted as advisor to Ambea AB (publ) together with the Finnish law firm Krogerus in connection with the acquisition of Validia Oy from Invalidiliitto, the Finnish Association for the Disabled, a leading care provider in Finland. Through the acquisition, Ambea establishes a presence in the Finnish market and strengthens its position as the only care provider with operations in the four largest Nordic countries. The purchase price amounts to a total of SEK 1, 382 million.
March 12, 2025

Vinge advises on the sale of Road Rental

 Vinge has advised Sobro and other shareholders in connection with the sale of Road Rental to BUKO Group, a leading European actor within temporary traffic management solutions. This strategic partner will give Road Rental access to a broad international network, strong resources and expertise which will enable continued expansion in Sweden as well as the rest of Scandinavia.
March 12, 2025

Vinge has advised Röko in connection with its listing on Nasdaq Stockholm

 Vinge has advised Röko AB (publ) (“Röko”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on March 4, 2025 and the first day of trading is March 11, 2025.
March 11, 2025